Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Systematic Review and Network Meta-Analysis of Frontline Targeted Therapy in Chronic Lymphocytic Leukemia Shows Comparable Efficacy but Distinct Toxicity

Laurie K Pearson, Mumtu Lalla, Philip Tracy, Raveendhara R Bannuru, Andreas K Klein

Blood (2022) 140 (Supplement 1): 12423–12424.

https://doi.org/10.1182/blood-2022-156499

Published: 2022

Journal Articles

Successful Desensitization of Severe Alloimmune Platelet Refractoriness and Provision of Permissive Platelet Transfusions with a Novel IgG-Targeted Enzyme Therapeutic

Adnan Qamar, Laurie K Pearson, John Xin, Andreas K Klein, Jensyn Cone Sullivan

Blood (2022) 140 (Supplement 1): 8562–8563.

https://doi.org/10.1182/blood-2022-169735

Published: 2022

Journal Articles

Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

Andrew M. Evens, Alexey Danilov, Deepa Jagadeesh, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Daniel Rector, Suchitra Sundaram, Nishitha Reddy, Yong Lin, Umar Farooq, Christopher D'Angelo, David A. Bond, Stephanie Berg, Michael C. Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Maryam Yazdy, Emma Rabinovich, Gaurav Varma, Reem Karmali, Agrima Mian, Malvi Savani, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine Diefenbach, Allandria Straker-Edwards, Andreas K. Klein, Kristie A. Blum, Kirsten Marie Boughan, Scott E. Smith, Brad M. Haverkos, Victor M. Orellana-Noia, Vaishalee P. Kenkre, Adam Zayac, Jeremy Ramdial, Seth M. Maliske, Narendranath Epperla, Parameswaran Venugopal, Tatyana A. Feldman, Stephen D. Smith, Andrzej Stadnik, Kevin A. David, Seema Naik, Izidore S. Lossos, Matthew A. Lunning, Paolo Caimi, Manali Kamdar, Neil Palmisiano, Veronika Bachanova, Craig A. Portell, Tycel Phillips, Adam J. Olszewski, Juan Pablo Alderuccio

Blood (2021) 137 (3): 374–386.

https://doi.org/10.1182/blood.2020006926

Published: 2021

Includes: Supplemental data

Journal Articles

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Sandy W. Wong, MD, Melissa Warner, BS, Alejandro Moreno-Koehler, MPH, Athena Kritharis, MD, Michael E Coyle, MD, Deborah Black, RN, BSN, Valerie Relias, PharmD, BCOP, Terry Fogaren, RN, BSN, Nancy Cody Lyons, NP, Francois Toka, NP-C, Denise Larivee, RN, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Grace Kao, MD, Kellie Sprague, MD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD

Blood (2015) 126 (23): 5496.

https://doi.org/10.1182/blood.V126.23.5496.5496

Published: 2015

Journal Articles

Photopheresis As Part of Conditioning Reduces Incidence of Severe Graft Versus Host Disease: Fourteen Year Follow-up of a Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Esha Kaul, MD, Gunjan L Shah, MDMS, Aaron S. Rosenberg, MD, Raymond L. Comenzo, MD, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Furha I. Cossor, MD, Grace S. Kao, MD, Kenneth B. Miller, MD, Andreas K. Klein, MD, Kellie A. Sprague, MD

Blood (2014) 124 (21): 5924.

https://doi.org/10.1182/blood.V124.21.5924.5924

Published: 2014

Journal Articles

Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder (HL-PTLD) after Solid Organ Transplant (SOT): A Comprehensive and Comparative Analysis of Disease Characteristics, Prognosis, and Survival

Aaron S. Rosenberg, MD, Andreas K. Klein, MD, Robin Ruthazer, MPH, Andrew M. Evens, DO, MSc

Blood (2014) 124 (21): 502.

https://doi.org/10.1182/blood.V124.21.502.502

Published: 2014

Journal Articles

Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis

Ojas H. Vyas, MD, Esha Kaul, MD, Aaron S. Rosenberg, MD, Gunjan L Shah, MDMS, Urvi Ajay Shah, MD, Raymond L. Comenzo, MD, Grace Shih-Hui Kao, MD, Andrew M. Evens, DO, MSc, Hedy Smith, MDPhD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Kellie A. Sprague, MD

Blood (2014) 124 (21): 3170.

https://doi.org/10.1182/blood.V124.21.3170.3170

Published: 2014

Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome

Blood (2014) 124 (21): 1703.

https://doi.org/10.1182/blood.V124.21.1703.1703

Published: 2014

Journal Articles

Hepatitis B (HBV) Screening in Patients Receiving Rituximab: A Comprehensive Analysis Including Comparison of Adherence By Oncologists and Non-Oncologists

Aditi Puri, MD, Ryan L. Stevenson, MD, Jack Khouri, MD, Raymond L. Comenzo, MD, Grace Shih-Hui Kao, MD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Aaron Rosenberg, MD MS, Hedy Smith, MDPhD, Kellie A. Sprague, MD, Valerie Relias, PharmD, Andrew M. Evens, DO, MSc

Blood (2014) 124 (21): 2595.

https://doi.org/10.1182/blood.V124.21.2595.2595

Published: 2014

Journal Articles

Multiple Myeloma and Plasmactyoma-Like Post-Transplant Lymphoproliferative Disorders (PTLD): Examination Of Outcomes and Prognostication In The Modern Era

Aaron S. Rosenberg, MD, Robin Ruthazer, MPH, Jessica K Paulus, ScD, Andrew M Evens, DO, MSc, Andreas K. Klein, MD

Blood (2013) 122 (21): 1899.

https://doi.org/10.1182/blood.V122.21.1899.1899

Published: 2013

Journal Articles

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Chakra P Chaulagain, MD, FACP, Esha Kaul, MD, Monika Pilichowska, MD, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD

Blood (2013) 122 (21): 5496.

https://doi.org/10.1182/blood.V122.21.5496.5496

Published: 2013

Journal Articles

Cost-Implications Of Comorbidity For Autologous Hematopoietic Stem Cell Transplantation (Auto HSCT) In Elderly Patients With Multiple Myeloma (MM) Using The SEER-Medicare Database

Gunjan L. Shah, MD MS, Aaron Winn, MPP, Andreas K. Klein, MD, Kellie Sprague, MD, Joshua T. Cohen, PhD, Kenneth B. Miller, MD, Susan K. Parsons, MD, MRP

Blood (2013) 122 (21): 1746.

https://doi.org/10.1182/blood.V122.21.1746.1746

Published: 2013

Journal Articles

Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era

Blood (2013) 122 (21): 847.

https://doi.org/10.1182/blood.V122.21.847.847

Published: 2013

Journal Articles

Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity.

Gunjan L Shah, MD MS, Esha Kaul, MD, Shelly Fallo, RPh, Furha I. Cossor, MD MS, Hedy Smith, MD PhD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD

Blood (2012) 120 (21): 2968.

https://doi.org/10.1182/blood.V120.21.2968.2968

Published: 2012

Journal Articles

Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia

Katie O'Callaghan, Lydia Lee, Nga Nguyen, Mo-Ying Hsieh, Nicole C. Kaneider, Andreas K. Klein, Kellie Sprague, Richard A. Van Etten, Athan Kuliopulos, Lidija Covic

Blood (2012) 119 (7): 1717–1725.

https://doi.org/10.1182/blood-2011-04-347518

Published: 2012

Includes: Supplemental data

Journal Articles

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Furha I. Cossor, MD, Sandy Wong, MD, Kenneth B Miller, MD, Deborah Black, RN, Raymond L. Comenzo, MD, Andreas K. Klein, MD, Alanna Klekar, RN, Valerie Relias, PharmD, Hedy Smith, MD, PhD, Kellie Sprague, MD, Karen M Switkowski, MS, MPH, Richard A. Van Etten, MD PhD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4153.

https://doi.org/10.1182/blood.V118.21.4153.4153

Published: 2011

Journal Articles

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Deepa Jeyakumar, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Andreas K. Klein, MD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4506.

https://doi.org/10.1182/blood.V118.21.4506.4506

Published: 2011

Journal Articles

Targeting CXCR4 with Cell-Penetrating Pepducins Enhances Survival in Disseminated Lymphoma

Lidija Covic, Katie M O’Callaghan, PhD, Nga Ngyen, Hsieh Mo-Ying, Andreas K. Klein, MD, Kellie Sprague, MD, Richard A. Van Etten, MD PhD, Athan Kuliopulos, MD, PhD

Blood (2011) 118 (21): 4244.

https://doi.org/10.1182/blood.V118.21.4244.4244

Published: 2011

Journal Articles

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Hans-Georg Klingemann, MD, PhD, Carrie Grodman, RN, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Tarun Kewalramani, MD, Raymond L. Comenzo, MD, Neng Yu, MD, Marvin Duque, MD, Richard A. Van Etten, MD, PhD, David McKenna, MD

Blood (2010) 116 (21): 4299.

https://doi.org/10.1182/blood.V116.21.4299.4299

Published: 2010

Journal Articles

Apoptosis in Response to Inhibition of Dipeptidyl Peptidase 2 (DPP2) Defines Low Risk Chronic Lymphocytic Leukemia (CLL).

Alexey V. Danilov, MD, Olga V. Danilova, PhD, Andreas K. Klein, MD, Brigitte T. Huber, PhD

Blood (2007) 110 (11): 3094.

https://doi.org/10.1182/blood.V110.11.3094.3094

Published: 2007

NARROW

Systematic Review and Network Meta-Analysis of Frontline Targeted Therapy in Chronic Lymphocytic Leukemia Shows Comparable Efficacy but Distinct Toxicity

Successful Desensitization of Severe Alloimmune Platelet Refractoriness and Provision of Permissive Platelet Transfusions with a Novel IgG-Targeted Enzyme Therapeutic

Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Photopheresis As Part of Conditioning Reduces Incidence of Severe Graft Versus Host Disease: Fourteen Year Follow-up of a Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder (HL-PTLD) after Solid Organ Transplant (SOT): A Comprehensive and Comparative Analysis of Disease Characteristics, Prognosis, and Survival

Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis

Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome

Hepatitis B (HBV) Screening in Patients Receiving Rituximab: A Comprehensive Analysis Including Comparison of Adherence By Oncologists and Non-Oncologists

Multiple Myeloma and Plasmactyoma-Like Post-Transplant Lymphoproliferative Disorders (PTLD): Examination Of Outcomes and Prognostication In The Modern Era

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Cost-Implications Of Comorbidity For Autologous Hematopoietic Stem Cell Transplantation (Auto HSCT) In Elderly Patients With Multiple Myeloma (MM) Using The SEER-Medicare Database

Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era

Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity.

Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Targeting CXCR4 with Cell-Penetrating Pepducins Enhances Survival in Disseminated Lymphoma

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Apoptosis in Response to Inhibition of Dipeptidyl Peptidase 2 (DPP2) Defines Low Risk Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only